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Atopic dermatitis is a chronic inflammatory disease, usually associated with a personal or family history of atopic diseases 
such as AD, allergic rhinitis or asthma that most commonly arise in childhood and present with elevated IgE serum in up to 85% of 
patients. The severity of AD is based on the extent of affected areas, itch intensity and appearance of skin lesions. 
Here, we present the case of a 21-year-old female patient with generalized erythematous eczematous skin lesions, flexural 
lichenifications accompanied by intense pruritus, painful fissures and erosions resulting from scratching. She also presented 
erythematous plaques with thin scales on the scalp. The patient had no personal or familial history of AD, allergic rhinitis or asthma 
and the onset of cutaneous symptoms presented severe exacerbation in the last 2 months of the last 3 years. The main laboratory 
findings were- high serum eosinofilia (2,400/μL) and very high total IgE serum (11449UI/L). The flare remission was induced with 
systemic treatment (corticotherapy, oral H1 antihistamines, and antibiotherapy) and topical therapy (UVB 311nm, topical 
glucocorticoids and hydration). 
It is very important to recognize AD as a cause of erythroderma, especially in a patient with a late onset of the disease, in 
order to treat it promptly and to prevent ulterior recurrences, by educating the patient to have an adequate life style and to treat the 
recurrences at the very first symptoms. 
Introduction 
Atopic dermatitis is an inflammatory, relapsing, 
chronic skin disease that usually begins in infancy and it 
presents with dry skin, erythematous-edematous and 
veziculous papules and plaques accompanied by intense 
pruritus. Rubbing and scratching lead to erosions, fissures 
and lichenification. The predilected sites are flexures, 
neck, face, eyelids, wrists and dorsa of feet and hands or 
can be generalized in severe disease [1]. The lesions are 
easily colonized with Staphylococcus aureus which 
exacerbates the skin inflammation and maintains the 
vicious cycle by secreting exotoxins that may act as 
superantigens stimulating the activation of T cells and 
macrophages [1,2]. 
Atopic dermatitis is frequently associated with a 
personal or family history of atopic diseases such as 
atopic dermatitis, allergic rhinitis or asthma. Significant 
proportions of affected children have persistent atopic 
dermatitis after puberty and are at risk of developing 
respiratory allergies. The underlying pathophysiologic and 
genetic mechanisms are yet unknown but involve 
interactions between genetic factors, the immune system 
and the environment [3]. 
The diagnosis is based on clinical aspects of the 
lesions, the most frequently used criteria being those 
proposed by Hanifin and Rajka. Three of four major 
criteria are necessary – pruritus, typical morphology and 
distribution, chronically relapsing course and atopic 
personal or family history, in addition to three other signs 
of atopy like xerosis, keratosis pilaris, palmar 
hyperliniarity, Dennie-Morgan infraorbital fold, periocular 
pigmentation, the Hertoghe sign of the lateral eyebrow, 
“white dermografism, cheilitis, conjunctivitis, keratoconus, 
subcapsular anterior cataract [1]. 
Food allergy is an important trigger of atopic 
dermatitis. Skin prick tests or specific IgE serum have a 
high negative predictive value when they are negative. 
When they are positive they should be followed by 
placebo controlled oral food challenges in patients without 
history of life threatening reactions after the ingestion of 
specific food for preventing unnecessary dietary limitations 
[4-9]. Skin prick tests or specific IgE serum are useful to 
determine sensitivity to inhalant allergens such as house 
dust mite and animal dander [5,10-12]. Up to 85% of 
patients have an elevated IgE serum level. 
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The grading of the severity of atopic dermatitis is 
based on the extent of affected areas, itch intensity and 
appearance of skin lesions. The disease can complicate 
with erythroderma and risk of exfoliation, ocular 
complications such as keratoconus or keratoconjuctivitis 
sleep disturbances, psychological disturbances, and 
bacterial or viral skin infections. 
The treatment is complex and requires short term 
control of acute symptoms followed by long term 
stabilization and flare prevention with minimal side effects 
[2,13,14]. 
Case presentation 
We present the case of D.F., a 21-year-old female 
patient, with generalized erythematous skin lesions, 
flexural lichenifications accompanied by intense pruritus, 
painful fissures and erosions resulting from scratching. 
The whole body was covered with fine branny scales. She 
also presented erythematous plaques with thin scales on 
the scalp. The onset of cutaneous symptoms lasted for 3 
years before the admission in our clinic with xerosis and 
erythematous and edematous plaques on the arms, neck 
and face, accompanied by intense pruritus. She was 
ocasionally treated with oral antihistamines but the lesions 
progressed in time on the trunk and legs. The scratching 
led to erosions and lichenification followed by painful 
fissures on the neck , anterior torax and at the flexures. 
The patient had no personal or familial history of 
allergic rhinitis or asthma. She had no other chronic 
medical conditions and was not on any medication. 
Physical examination, revealed a strong pulse, with a 
regular heart rhythm and a rate of 84 bpm, blood pressure 




















The complete blood count (CBC) showed 
leukocytosis (a white blood cell count of 11,3 × 103/µL) 
with high serum eosinofilia (2,440/µL), and very high total 
IgE serum (11449UI/L). Skin punch biopsy showed 
moderate acanthosis and spongiosis and dermal 
infiltration composed of lymphocytes, hystiocytes and 
eosinophils. In atopic dermatitis, histopathology is 
nonspecific, being useful for differential diagnosis. 
Differential diagnosis in this case, included other 
conditions that could lead to exfoliative erythrodermic 
syndrome: erythrodermic psoriasis, lymphoma, leukemia, 
cutaneous drug reaction, allergic contact dermatitis, 
seborrheic dermatitis, pityriazis rubra pilaris and 
pemphigus foliaceus. 
After definite diagnosis, the treatment was started 
promptly. She received a high dose of systemic 
corticosteroids -Prednisone 40mg (0,75mg/kgC) with 
gradual tapering of dose with 5 mg every 3 days, to a daily 
dose of 20 mg, then with a slower decrease, 5 mg every 
week, to prevent the rebound of symptoms. She also 
received a 7 days systemic antibiotherapy and oral 
antihistamines. Intensified skin hydration and topical 
corticosteroids were instituted during the tapering period, 
in order to suppress the rebound flaring associated with 
the narrow UVB band (311nm). 
The evolution was very good, with a complete 
clearance of lesions in about six weeks. After the 
cessation of systemic therapy and topical corticosteroids 
we insisted on a long term maintenance therapy with 
adequate cleaning and hydration of the skin, avoiding the 



















After 2 weeks of treatment : considerable improvement of 
lesions  
Discussions 
Exfoliative erythroderma is a serious, possible life 
threatening reaction. There is considerable heat 
dissipation and fluid loss due to the dilatation of 
capillaries. Moreover, high output cardiac failure, 
electrolyte imbalance and loss of serum protein may 
appear due to exfoliation. The patient may feel cold and 
present pruritus, fatigue, weakness, anorexia, weight loss 
and malaise. There is a high risk of secondary skin 
infection with S. aureus and even sepsis. Treatment 
First presentation : eritematous-edematous , veziculous , 
extensive lesions  with lichenification and erosions from 
scratching          
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should be instituted promptly, with supportive measures 
such as fluid and electrolyte replacement, systemic 
antibiotherapy if signs of infection are still present in the 
treatment of the underlying disease. Diagnosis is difficult 
and it is  based on the history of the preexisting disease 
and pathognomonic signs and symptoms. [2] 
In this case, the late onset of the disease and the 
lack of personal or familial history of atopic diseases made 
the diagnosis harder to put. Arguments pro atopic 
dermatitis diagnosis were intense pruritus, lichenifications 
at flexures and on the neck and the high IgE serum level.  
We put differential diagnosis with other possible 
causes of erythrodermic reactions. The graduate onset, 
and the considerable period of time since the beginning of 
symptoms excluded a cutaneous drug reaction. 
Psoriasis generally presents hyperkeratotic plaques of 
scalp or knees and elbows. The skin punch biopsy 
showes parakeratotic hyperkeratosis and 
polymorphonuclear cells in the epidermis forming 
microabcesses of Munro in the stratum corneum. Severe 
allergic contact dermatitis presents with an eruption that 
starts in a sensitized patient after repeated exposures to 
the allergen at the site of exposure with ulterior 
generalization.  Sezary syndrome is a variant of 
cutaneous T cell lymphoma presenting erythroderma, 
peripheral lymphadenopathy and cellular infiltrations of 
atypical lymphocytes in the skin and blood. It usually 
occurs in patients over 60 years old.  Pemphigus 
foliaceus may present as exfoliative erythroderma. It is a 
superficial form of pemphigus, with acantholysis in the 
granular layer of epidermis due to the circulation of 
autoantibodies to a 160-kDa intercellular antigen 
(desmoglein 1), in the desmosomes of keratinocytes.  
The intensive treatment, the lack of other chronic 
medical conditions and the good cooperation with the 
patient helped in the complete resolution of lesions without 
other complications or side effects. Systemic anti-
inflammatory treatment for the acute phase is rapidly 
effective, but long-term use should be avoided, as side 
effects are inevitable. Topical therapy should be instituted 
with a tapering of the doses in order to prevent the 
rebound flaring. 
Considering that atopic dermatitis is a chronic 
relapsing disease, it is very important that the patient 
understands her condition in order to have an adequate 
life style and, in the mean time, to avoid unnecessary 
measures and constrains [3,13]. 
The skin must be thoroughly cleansed with non-
irritant and low allergic formulas. The bath should be short 
and the use of bath oils is necessary to avoid dehydration.  
 
Topical emollients should be applied directly after the bath 
for a better penetration, after the gentle drying of the skin.  
Emollients should be used twice, daily, in order to 
reestablish and preserve the hydrolipid film of the skin, 
and restore the epidermal barrier function, which is able to 
prevent water loss and allergen penetration trough 
damaged skin [14]. Studies show that moisturizers used 
regularly decrease the need for topical corticosteroids [3]. 
Avoiding the irritants such as detergents, chlorine in 
the pool water, rough clothing fabrics or wool is necessary 
because they can contribute to the alteration of skin 
barrier favorising water loss [3]. In addition, the 
environmental temperature and humidity should be 
moderate to avoid excessive sweating. It is important to 
control the exposure to allergens such as house dust mite 
or animal dander. Individual food allergies should be 
investigated and incriminated aliments should be removed 
from the diet [ 8]. Contact sensitizations should be 
diagnosed and implicated factors avoided [15,16]. 
A broad set of immunomodulatory agents have been 
used for severe atopic dermatitis refractory to other 
therapies, but their use is limited because of systemic 
toxicities and high costs. Cyclosporine A is a systemic 
calcineurin inhibitor used after organ transplantation. 
Multiple studies demonstrated that patients with refractory 
disease benefit from short-term cyclosporine treatment. 
However, the disease relapses rapidly after cessation of 
therapy. This therapy is associated with systemic side 
effects such as elevated serum creatinine level, renal 
impairment or hypertension. Topical calcineurin inhibitors 
– Tacrolimus and Pimecrolimus- are safe and effective 
therapy for children of 2 years old and older and for adults. 
The most frequent side effect was a burning sensation at 
the application site. Due to the fact that it may restore the 
immunologic Th1-Th2 imbalance, the recombinant 
interferon-γ, showed persistent long term improvement. 
However, the wide use has been limited by its high cost 
and difficulty in predicting responders. Intravenous 
immunoglobulin showed good responses and should be 
considered in refractory cases, but the major 
disadvantage is the high cost [3,13]. 
Conclusions 
It is very important to recognize atopic dermatitis as 
a cause of erythroderma, especially in a patient with late 
onset of the disease and no personal or familial history of 
allergic diseases. Moreover, it is of high interest to treat it 
promptly and to prevent ulterior recurrences by educating 
the patient to have an adequate life style and to treat the 
flares at the very first symptoms. 
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